证券记录 · 已归档季度
NTRA
Natera, Inc. · Healthcare · Medical - Diagnostics & Research
23被追踪持有人
+1Δ持有人
81.70M持有股份
$13.15B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +4.5% ·
股份流向 +0.5% ·
净新建仓位 0.0%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | 0 | 104.13M | $28.25B | +5 | −4 |
| Q1 2026 | 164 | +3 | 98.65M | $19.54B | +6 | −4 |
| Q4 2025 | 160 | 0 | 102.31M | $23.44B | +1 | — |
| Q3 2025 | 23 | +1 | 81.70M | $13.15B | +1 | −1 |
| Q2 2025 | 20 | -1 | 57.32M | $9.68B | — | −1 |
| Q1 2025 | 18 | 0 | 31.15M | $4.40B | — | — |
| Q4 2024 | 18 | 0 | 26.97M | $4.27B | — | — |
| Q3 2024 | 17 | -1 | 21.42M | $2.72B | — | −1 |
| Q2 2024 | 18 | — | 16.29M | $1.76B | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | JPMorgan Chase ✦ | 23.26M | — | $3.74B | 0.1% | n/c | 1 | SEC ↗ ×34 |
| 2 | The Vanguard Group ✦ (被动) | 12.39M | -2.3% | $1.99B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | T. Rowe Price ✦ | 11.95M | -2.0% | $1.92B | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 4 | BlackRock ✦ (被动) | 10.96M | +0.1% | $1.76B | 0.0% | ▲ Add | 2 | SEC ↗ ×22 |
| 5 | State Street Global Advisors ✦ (被动) | 3.39M | +2.2% | $545.62M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Duquesne Family Office ✦ | 3.21M | +4.2% | $517.44M | 13.2% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 2.60M | +1.7% | $417.63M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Wellington Management ✦ | 2.56M | -3.0% | $411.45M | 0.1% | ▼ Trim | 6 | SEC ↗ ×8 |
| 9 | AQR Capital Management ✦ | 2.40M | +39.0% | $386.34M | 0.2% | ▲ Add | 6 | SEC ↗ ×7 |
| 10 | Capital World Investors ✦ | 1.41M | +0.2% | $227.41M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 1.28M | — | $206.58M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 12 | Fidelity (FMR) ✦ | 1.11M | -23.4% | $179.22M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 13 | Goldman Sachs Group ✦ | 1.10M | — | $177.31M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 14 | Citadel Advisors ✦ | 896.67K | +9.2% | $144.34M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | ARK Investment Management ✦ | 892.59K | -4.7% | $143.68M | 0.9% | ▼ Trim | 6 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 558.99K | +15.7% | $89.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 17 | Millennium Management ✦ | 527.94K | +199.1% | $84.98M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 298.50K | -39.5% | $48.05M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 281.57K | +11.5% | $45.32M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 238.96K | +1.7% | $38.47M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 21 | Coatue Management ✦ | 170.33K | 新增 | $27.42M | 0.1% | New | 1 | SEC ↗ ×7 |
| 22 | D. E. Shaw & Co. ✦ | 132.16K | -24.0% | $21.27M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 23 | Gotham Asset Management ✦ | 71.63K | -29.5% | $11.53M | 0.1% | ▼ Trim | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Coatue Management | $27.42M | 0.1% |
已清仓
| Norges Bank | $277.75M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 755 持有人, 120.14M 股份, $20.15B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 01
Chapman Steven Leonard
Officer, Director · 1.27K 股 · $526,144
Sep 23
Sheena Jonathan
Director · 1.94K 股 · $754,090
Sep 23
Sheena Jonathan
Director · 1.34K 股 · $521,332
Sep 23
Sheena Jonathan
Director · 2.85K 股 · $1.10M
Sep 23
Sheena Jonathan
Director · 2.30K 股 · $889,271
Sep 23
Sheena Jonathan
Director · 390 股 · $150,263
Sep 23
Sheena Jonathan
Director · 110 股 · $42,946
Sep 23
Sheena Jonathan
Director · 2.32K 股 · $904,069
Sep 23
Sheena Jonathan
Director · 1.29K 股 · $502,598
Sep 23
Sheena Jonathan
Director · 2.73K 股 · $1.06M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据